Morgan Woods

499 total citations
12 papers, 386 citations indexed

About

Morgan Woods is a scholar working on Molecular Biology, Urology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Morgan Woods has authored 12 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Urology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Morgan Woods's work include Urinary Bladder and Prostate Research (4 papers), Neuropeptides and Animal Physiology (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Morgan Woods is often cited by papers focused on Urinary Bladder and Prostate Research (4 papers), Neuropeptides and Animal Physiology (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Morgan Woods collaborates with scholars based in United States and Canada. Morgan Woods's co-authors include Thomas M. Argentieri, N. Wesley Norton, Jeffrey H. Sheldon, B. G. CHRISTENSEN, L. D. Cama, T. N. SALZMANN, John A. Butera, Walter Spinelli, Schuyler Antane and Dominick Quagliato and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Urology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Morgan Woods

10 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morgan Woods United States 9 141 126 114 43 43 12 386
Jeffrey H. Sheldon United States 11 160 1.1× 104 0.8× 154 1.4× 50 1.2× 49 1.1× 16 441
N. Wesley Norton United States 9 169 1.2× 101 0.8× 152 1.3× 45 1.0× 52 1.2× 11 482
Robert J. Altenbach United States 15 235 1.7× 239 1.9× 48 0.4× 20 0.5× 45 1.0× 27 533
Naoyuki Masuda Japan 14 162 1.1× 179 1.4× 82 0.7× 5 0.1× 17 0.4× 27 490
Counde O-Yang United States 13 311 2.2× 266 2.1× 16 0.1× 18 0.4× 54 1.3× 22 649
Schuyler Antane United States 10 174 1.2× 244 1.9× 42 0.4× 29 0.7× 29 0.7× 13 425
S. Cacciaguerra Italy 12 176 1.2× 135 1.1× 17 0.1× 12 0.3× 76 1.8× 26 408
Akiko Mitani Japan 12 80 0.6× 28 0.2× 45 0.4× 4 0.1× 27 0.6× 28 401
Hee Kyung Kang South Korea 12 190 1.3× 40 0.3× 13 0.1× 24 0.6× 25 0.6× 17 647
Bryan W. Sherman United States 8 181 1.3× 69 0.5× 13 0.1× 19 0.4× 24 0.6× 11 369

Countries citing papers authored by Morgan Woods

Since Specialization
Citations

This map shows the geographic impact of Morgan Woods's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan Woods with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan Woods more than expected).

Fields of papers citing papers by Morgan Woods

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan Woods. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan Woods. The network helps show where Morgan Woods may publish in the future.

Co-authorship network of co-authors of Morgan Woods

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan Woods. A scholar is included among the top collaborators of Morgan Woods based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan Woods. Morgan Woods is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Dai, Xing, Andrew W. Stamford, Hong Liu, et al.. (2015). Discovery of the oxazabicyclo[3.3.1]nonane derivatives as potent and orally active GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 25(22). 5291–5294. 5 indexed citations
2.
Xia, Yan, Samuel Chackalamannil, William J. Greenlee, et al.. (2011). Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 21(11). 3290–3296. 34 indexed citations
3.
Zhang, Xuqing, Yuhong Qiu, Xiaojie Li, et al.. (2008). Discovery and structure–activity relationships of a novel series of benzopyran-based KATP openers for urge urinary incontinence. Bioorganic & Medicinal Chemistry. 17(2). 855–866. 9 indexed citations
4.
Woods, Morgan, et al.. (2001). EFFICACY OF THE β3-ADRENERGIC RECEPTOR AGONIST CL-316243 ON EXPERIMENTAL BLADDER HYPERREFLEXIA AND DETRUSOR INSTABILITY IN THE RAT. The Journal of Urology. 166(3). 1142–1147. 89 indexed citations
5.
6.
Gilbert, A., Thomas M. Argentieri, John A. Butera, et al.. (2000). Design and SAR of Novel Potassium Channel Openers Targeted for Urge Urinary Incontinence. 2. Selective and Potent Benzylamino Cyclobutenediones. Journal of Medicinal Chemistry. 43(6). 1203–1214. 47 indexed citations
7.
Butera, John A., Schuyler Antane, Thomas M. Argentieri, et al.. (2000). Design and SAR of Novel Potassium Channel Openers Targeted for Urge Urinary Incontinence. 1. N-Cyanoguanidine Bioisosteres Possessing in Vivo Bladder Selectivity. Journal of Medicinal Chemistry. 43(6). 1187–1202. 70 indexed citations
8.
Woods, Morgan, Walter Spinelli, Thomas Colatsky, et al.. (1999). Comparison of the Potassium Channel Openers, WAY-133537, ZD6169, and Celikalim on Isolated Bladder Tissue and In Vivo Bladder Instability in Rat. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1410–1418. 46 indexed citations
9.
Cama, L. D., et al.. (1987). Modification of natural products to improve their biological properties. Pure and Applied Chemistry. 59(3). 455–458. 13 indexed citations
10.
Cama, L. D., et al.. (1987). Structure-activity relationships in the 2-arylcarbapenem series. Synthesis of 1-methyl-2-arylcarbapenems. Journal of Medicinal Chemistry. 30(5). 871–880. 61 indexed citations
11.
Mrozik, Helmut, John C. Chabala, Philip Eskola, et al.. (1983). Synthesis of milbemycins from avermectins. Tetrahedron Letters. 24(48). 5333–5336. 12 indexed citations
12.
Chabala, John C., Helmut Mrozik, Richard L. Tolman, et al.. (1981). ChemInform Abstract: IVERMECTIN, A NEW BROAD‐SPECTRUM ANTIPARASITIC AGENT. Chemischer Informationsdienst. 12(10).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey H. Sheldon Breakdown of academic impact, for papers by N. Wesley Norton Breakdown of academic impact, for papers by Robert J. Altenbach Breakdown of academic impact, for papers by Naoyuki Masuda Breakdown of academic impact, for papers by Counde O-Yang Breakdown of academic impact, for papers by Schuyler Antane Breakdown of academic impact, for papers by S. Cacciaguerra Breakdown of academic impact, for papers by Akiko Mitani Breakdown of academic impact, for papers by Hee Kyung Kang Breakdown of academic impact, for papers by Bryan W. Sherman
Rankless by CCL
2026